UK MHRA commences accelerated review for AstraZeneca’s COVID-19 vaccine candidate
In rolling reviews, regulators can see clinical data in real-time and have discussions with pharma companies on manufacturing…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
ChAdOx1 nCoV-19
Oxford COVID-19 vaccine trials produce robust immune response in elderly: FT
AstraZeneca, which is developing the vaccine with Oxford University researchers, is seen as a frontrunner in the race to produce a…
Project leader: Oxford’s COVID-19 vaccine trial has 50 per cent chance of success
The experimental vaccine, known as ChAdOx1 nCoV-19, is one of the front-runners in the global race to provide protection against…
AstraZeneca and Oxford University sign agreement for COVID-19 vaccine
The collaboration will enable global development, manufacturing and distribution of the vaccine
HALIX and University of Oxford collaborate for GMP manufacturing of COVID-19 Vaccine
The nCoV-19 vaccine is based on the Jenner Institute’s adenovirus vaccine vector (ChAdOx1) technology, which was chosen as the…